NOVAVAX INC Stock Issued During Period, Shares, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NOVAVAX INC stock issued during period, shares, new issues for the quarter ending 2017-09-30 was 19.90M shares.
- NOVAVAX INC stock issued during period, shares, new issues for the quarter ending 2017-06-30 was 7.30M shares.
- NOVAVAX INC stock issued during period, shares, new issues for the quarter ending 2017-03-31 was 10.70M shares.
- NOVAVAX INC stock issued during period, shares, new issues for the quarter ending 2013-09-30 was 8.00M shares.
- NOVAVAX INC stock issued during period, shares, new issues for fiscal 2012 was 8.44M shares, a 40.66% increase from fiscal 2011.
- NOVAVAX INC stock issued during period, shares, new issues for fiscal 2011 was 6.00M shares, a 42.91% decline from fiscal 2010.
- NOVAVAX INC stock issued during period, shares, new issues for fiscal 2010 was 10.51M shares.
| Period end | Stock Issued During Period, Shares, New Issues 3 month | Stock Issued During Period, Shares, New Issues 12 month |
|---|---|---|
| 2017-09-30 | 19.90M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | |
| 2017-06-30 | 7.30M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | |
| 2017-03-31 | 10.70M shares 10-Q · filed 2017-05-08 | |
| 2013-09-30 | 8.00M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | 12.64M shares derived: sum of 4 quarters · filed 2013-11-12 |
| 2013-06-30 | 1.30M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | |
| 2013-03-31 | 3.30M shares 10-Q · filed 2013-05-09 | |
| 2012-12-31 | 42.02K shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | 8.44M shares 10-K · filed 2013-03-12 |
| 2011-12-31 | 6.00M shares 10-K · filed 2013-03-12 | |
| 2010-12-31 | 10.51M shares 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |